National Cancer Institute; Notice of Closed Meeting, 32989 [06-5146]
Download as PDF
<![CDATA[
Federal Register / Vol. 71, No. 109 / Wednesday, June 7, 2006 / Notices
alternative approach may be used if
such approach satisfies the
requirements of the applicable statute
and regulations.
III. Electronic Access
Persons interested in obtaining a copy
of the guidance may do so by using the
Internet. To receive ‘‘Class II Special
Controls Guidance Document: Olfactory
Test Device,’’ you may either send an email request to dsmica@fda.hhs.gov to
receive an electronic copy of the
document or send a fax request to 240–
276–3151 to receive a hard copy. Please
use the document number 1595 to
identify the guidance you are
requesting.
CDRH maintains an entry on the
Internet for easy access to information
including text, graphics, and files that
may be downloaded to a personal
computer with Internet access. Updated
on a regular basis, the CDRH home page
includes device safety alerts, Federal
Register reprints, information on
premarket submissions [including lists
of approved applications and
manufacturers’ addresses], small
manufacturer’s assistance, information
on video conferencing and electronic
submissions, Mammography Matters,
and other device-oriented information.
The CDRH Web site may be accessed at
https://www.fda.gov/cdrh. A search
capability for all CDRH guidance
documents is available at https://
www.fda.gov/cdrh/guidance.html.
Guidance documents are also available
on the Division of Dockets Management
Internet site at https://www.fda.gov/
ohrms/dockets.
rwilkins on PROD1PC63 with NOTICES
IV. Paperwork Reduction Act of 1995
This guidance contains information
collection provisions that are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (the PRA) (44
U.S.C. 3501–3520). The collections of
information addressed in the guidance
document have been approved by OMB
in accordance with the PRA under the
regulations governing premarket
notification submissions (21 CFR part
807, subpart E, OMB control number
0910–0120). The labeling provisions
addressed in the guidance have been
approved by OMB under OMB control
number 0910–0485.
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES), written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
VerDate Aug<31>2005
17:54 Jun 06, 2006
Jkt 208001
32989
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Comments
received may be seen in the Division of
Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Dated: May 24, 2006.
Linda S. Kahan,
Deputy Director, Center for Devices and
Radiological Health.
[FR Doc. E6–8792 Filed 6–6–06; 8:45 am]
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–5146 Filed 6–6–06; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors for Basic
Sciences National Cancer Institute. The
meeting will be closed to the public as
indicated below in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Cancer Institutes, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors for Basic Sciences National
Cancer Institute.
Date: July 10, 2006.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31/Conference Room 6,
Bethesda, MD 20892.
Time: 7 p.m. to 11 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
National Cancer Institute, 9000 Rockville
Pike, Building 31/Conference Room 6,
Bethesda, MD 20892.
Contact Person: Florence E. Farber, PhD.,
Executive Secretary, Office of the Director,
National Cancer Institute, National Institutes
of Health, 6116 Executive Boulevard, Room
2115, Bethesda, MD 20892. 301–496–7628.
ff6p@nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
PO 00000
Frm 00077
Fmt 4703
Sfmt 4703
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Cancer Institute Board of
Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: June 29–30, 2006.
Time: June 29, 2006, 8 a.m. to 6 p.m.
Agenda: Director’s Report; Ongoing and
New Business; Reports Program Review
Group(s); and Budget Presentation; Reports of
Special Initiatives; RFA and RFP Concept
Review; and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Time: June 30, 2006, 8:30 a.m. to 1 p.m.
Agenda: Ongoing and New Business;
Reports of Program Review Group(s); and
Budget Presentation; Reports of Special
Initiatives; RFA and RFP Concept Review;
and Scientific Presentations.
Place: National Institutes of Health,
Building 31, C Wing, 6 Floor, Conference Rm.
10, 9000 Rockville Pike, Bethesda, MD
20892.
Contact Person: Paulette S. Gray, Ph.D.,
Executive Secretary, Director, Division of
E:\FR\FM\07JNN1.SGM
07JNN1
]]>Agencies
[Federal Register Volume 71, Number 109 (Wednesday, June 7, 2006)]
[Notices]
[Page 32989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-5146]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors for Basic Sciences National Cancer
Institute. The meeting will be closed to the public as indicated below
in accordance with the provisions set forth in section 552b(c)(6),
Title 5 U.S.C., as amended for the review, discussion, and evaluation
of individual intramural programs and projects conducted by the
National Cancer Institutes, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors for Basic
Sciences National Cancer Institute.
Date: July 10, 2006.
Time: 11 a.m. to 4 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, National Cancer Institute,
9000 Rockville Pike, Building 31/Conference Room 6, Bethesda, MD
20892.
Time: 7 p.m. to 11 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, National Cancer Institute,
9000 Rockville Pike, Building 31/Conference Room 6, Bethesda, MD
20892.
Contact Person: Florence E. Farber, PhD., Executive Secretary,
Office of the Director, National Cancer Institute, National
Institutes of Health, 6116 Executive Boulevard, Room 2115, Bethesda,
MD 20892. 301-496-7628. ff6p@nih.gov.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: May 31, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-5146 Filed 6-6-06; 8:45 am]
BILLING CODE 4140-01-M
